CLOSE X

H9 Cre-LoxP

This cell line is a modified version of WA09 (H9), engineered to contain a Cre-Lox site for ease in gene editing. It has also been engineered to constitutively express GFP. This combination allows the line, once further edited, to be traceable through GFP expression.
Cell Type Modified Human ES
Disease None reported
Genetic Modification Keyword Reporter; Constitutive
Sex Female
Genetically Related Cell Lines  
Provider University of Wisconsin - Dr. Su-Chun Zhang
dbGaP Data  
hPSCReg ID  
NIH Approval  
Pub Med Abstract  
Related Products
Collection(s) NIH Approved
Have you received this cell line previously? Yes No Why we ask
Quantity: Learn about our volume discounts

Current Lot Information

Lot Number Culture Platform Lot Description Passage Number Banked By Protocol Product Information & Testing
WB20971 mTeSR1/Matrigel   25 WiCell WiCell Feeder Independent Pluripotent Stem Cell Protocol PDF

Historical Lot Information

Lot Number Culture Platform Lot Description Banked By Protocol Product Information & Testing
MCB-01 mTeSR1/Matrigel Cre-Lox site WiCell WiCell Feeder Independent Pluripotent Stem Cell Protocol PDF